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About this paper 
 
The issue of growing out-of-pocket (OOP) costs and their impact on the ability of Australians to access 
needed health care is undermining the universality of Medicare, widening health inequalities and 
arguably leading to increased hospital costs. 
Currently, individual co‐payments comprise around 17% of total health care expenditure in Australia – 
the largest non‐government source of funding for health goods and services.1 This includes where 
individuals meet the full cost of goods and services ‐for example, medications that are not subsidised by 
the PBS, health services not subject to a Medicare rebate ‐ and where individuals share the cost of 
health goods and services with third party payers such as Medicare and private health insurance funds. 
 
This contribution by individuals represents a higher proportion of health care funding than in most other 
OECD countries and equates to $1,078 per capita. Moreover, in most OECD countries over the last 
decade the proportion of total expenditure coming from individual co‐payments has been decreasing, 
while in Australia out‐of‐pocket expenditure on health per capita continues to grow at a faster rate than 
the broader economy, average incomes and overall household expenditure.2  
 
Measured in current prices, out‐of pocket expenditure on health per capita has grown by 89.0% over the 
decade to 2011–12. In particular, total patient out‐of‐pocket expenses for primary and specialist care 
have significantly increased over the past 10 years, rising from $9.7 billion in 2001–02 to $17.1 billion in 
2011–12, a 76% increase.3 The average cost of a GP visit in 2013-14 was $47 from Medicare plus $5 from 
the patient.  For a private specialist, the average visit cost $82 from Medicare plus $38 from the 
patient.4  
 
About one-third of individuals’ out-of-pocket costs go for medicines, and although this includes 
nutritional supplements and ‘complementary’ and ‘alternative’ medicines, the out-of-pocket costs of 
essential over-the-counter and prescription medicines is also rising.5   
 
While these figures give a general guide to medical OOP costs, it is important to understand that in 
health care there are few ‘average’ patients.  That is because health care usage (and health care costs) 
are not evenly distributed across the population.  Increasing numbers of Australians are incurring high 
                                                          
1
 Senate Reference Committee on Community Affairs. Out-of-pocket costs in Australian healthcare. August 2014. 
http://www.aph.gov.au/parliamentary_business/committees/senate/community_affairs/australian_healthcare/~/
media/committees/clac_ctte/australian_healthcare/report.pdf 
 
2
 Ibid  
 
3
 Ibid  
 
4
 Britt H. General practice and value for money. John Menadue website 15 December 2014.  
http://johnmenadue.com/blog/?p=2922 
 
5
 Senate Reference Committee on Community Affairs. Out-of-pocket costs in Australian healthcare. August 2014. 
http://www.aph.gov.au/parliamentary_business/committees/senate/community_affairs/australian_healthcare/~/
media/committees/clac_ctte/australian_healthcare/report.pdf 
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OOP costs on a regular basis, due to factors such as their location, type of illness and the availability of 
public health care services.   
 
People with chronic illnesses and disabilities use health care much more often than the rest of the 
population and the increase in out-of-pocket costs falls disproportionately on this group, which already 
has a lower average income, thus compounding their financial disadvantage. So begins a vicious cycle, 
where those with poor health and fewer financial resources must pay proportionately more out-of-
pocket for their needed care, meaning they often go without. 
 
The Abbott Government has pushed to introduce or increase co-payments, claiming variously that 
growth in health care costs is unsustainable, price signals are need to reduce GP visits, budget deficits 
must be addressed and increased funding is needed for medical research. But targeting primary care for 
cost savings will quickly backfire. Research shows that while the number of GP visits has increased, these 
services are cost-effective; if the same services were performed in other areas of the health care system, 
they would cost considerably more.6 
The World Health Organisation has highlighted some of the potential negative consequences of co-
payments, including the fact that they are the least equitable form of health funding because they are 
regressive (the rich pay the same amount as the poor for any particular service).7 There is now a raft of 
Australian reports highlighting the adverse impacts of co-payments.8 
It is clear that whether the policy focus is on economic, health or social equity outcomes, greater 
attention needs to be paid to tackling rising out-of-pocket costs. With our ageing population and rising 
rates of chronic conditions, we can expect that there will be increasing numbers of Australians requiring 
long-term health and medical care from a range of different providers and in both hospital and 
community settings. Our current health care financing systems and safety-net arrangements are 
inadequate in meeting the needs of this group to ensure they can manage their health care costs and 
afford the services they need.   
This is a difficult topic – it involves a potent mix of evidence, ideology, consultation and leadership.  
There is no silver bullet and effective solutions are unlikely to be found through simple ‘add ons’ to our 
current health funding system, developed in an age where the majority of health care was for short-
term, acute problems. They are more likely to involve a multi-faceted approach and require a re-thinking 
of the ways in which we generate and allocate our health care resources and ensure health care funding 
decisions reflect our society’s underlying values. 
 
                                                          
6
 Britt H, Miller GC, Henderson J, et al. A decade of Australian general practice activity 2004–05 to 2013–14. 
General practice series no. 37. Sydney: Sydney University Press, 2014 
http://ses.library.usyd.edu.au/bitstream/2123/11883/4/9781743324240_ONLINE.pdf 
 
7
 WHO (2003). Drugs and Money: Prices, Affordability and Cost Containment.  
http://apps.who.int/medicinedocs/en/d/Js4912e/3.4.html 
 
8
 The most recent of these are summarised at Russell L. Analysis of 2014-15 Health Budget: Unfair and unhealthy.  
http://ses.library.usyd.edu.au//bitstream/2123/11981/1/2014-15healthbudget.pdf\ 
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To kick-start the necessary analyses, debates and policy formulations, we have developed this discussion 
paper which lays out some of the issues, as we see them.  It is admittedly short on solutions, but we are 
hopeful these will come. There is no shortage of collated evidence and expert advice available drive 
policy development – all that is needed is leadership. 
 
 
Lesley Russell       Jennifer Doggett 
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General approach 
 
The focus of this paper is on out-of-pocket (OOP) costs that arise from community-based care provided 
under Medicare by health care practitioners (GPs, specialists and allied health services).  While there are 
a range of other costs incurred by consumers when accessing health care, OOPs associated with 
Medicare-subsidised services are an important component of total health care costs for most consumers 
and reducing these, where they are a barrier to access, will increase overall access to care.   
Approaches that involve simply increasing the Medicare rebate and widening the current safety nets 
have been excluded as these would be unlikely to achieve the desired policy outcome and in any case 
would not be politically palatable.   
The approach taken is informed by the substantial evidence supporting the benefits of increasing access 
to primary care. There is convincing data from a range of sources that timely and affordable access to 
prevention and primary care services is key to improved health outcomes and sustainable health care 
costs.9 Indeed, we should not shy away from spending more on primary care if this is spent effectively 
and includes those who are currently under-served. We know that many Australians currently go 
without needed preventive and primary care services, especially those in rural and remote areas, people 
with mental illness and Indigenous Australians. Increasing access to primary health care for these groups 
can improve overall health outcomes, reduce the need for hospitalisation and increase the efficiency of 
resource allocation.   
It is important that any proposed changes are assessed against the following criteria: 
 
 Evidence-based; 
 Led by community values and priorities; 
 Do not increase inequality; 
 Do not reduce quality of care; 
 Recognise the business case for providers and take into account their preferred ways of working 
and professional cultures; 
 Are realistic within current legislative, workforce and political constraints; 
 Do not create unexpected consequences and inefficiencies elsewhere within the healthcare 
system; 
 Target those who most need assistance; and  
 Do not undermine the sustainability of the health care system. 
It will be important that the aims of any new proposals are clearly articulated and evaluated against 
these criteria.    
   
  
                                                          
9
 Department of Health and Ageing. Improving Primary Health Care for All Australians. 2011. 
http://webarchive.nla.gov.au/gov/20140801024641/http://www.yourhealth.gov.au/internet/yourhealth/publishin
g.nsf/Content/featurednews-20110222a 
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Preliminary research needed 
 
Some basic research is needed to provide the foundations and evidence for policy changes to address 
OOP costs in an effective and targeted fashion and to avoid predictable unintended consequences. 
 
What does the public want? 
There has been little or no attempt to engage the Australian people in the current political debate over 
health care costs. Taking the time and effort to consult with all the stakeholders, especially taxpayers, 
and obtain their feedback on new proposals is key to community buy-in, or at least understanding and 
acceptance of, changes in iconic federal programs like Medicare.   
We do not have a good sense of whether Australians think national spending on health care is at the 
right level and what they think is the appropriate mix of tax-funded / individual-funded contributions. 
There is some evidence of support for increasing the Medicare levy,10 although this has never been 
widely tested.   
In 2007, when Australia undertook a wide-ranging review of the health system via the National Health 
and Hospitals Reform Commission, there was no systematic process to gather community views. This 
differed from the approach taken by Canada which undertook a similar review and included a number of 
different processes to consult with consumers and the broader community on key health funding 
issues.11 Without such a consultative process Australian governments and policy makers are operating in 
a vacuum, developing policies based on unsubstantiated assumptions about community views.   
 
Who bears the burden of OOP costs? 
It is important that new policies target those with the largest OOP costs and those who have problems 
affording their health care expenses. These are not necessarily people on the lowest incomes or people 
with concession cards. Simply carving out exclusions on the basis of age or concessional status risks 
shifting costs to other vulnerable groups, thus widening inequalities and increasing preventable health 
problems.   
The first step in developing effective policies and programs to meet the needs of the most vulnerable is 
to find out more about them, including the following: 
 
 What are the greatest source/s of OOP costs?  
 Are all the costs incurred necessary?  
                                                          
10
 Why we’ll happily pay the Medicare Levy (just don’t call it a tax). Crikey  1 May 2013. 
http://www.crikey.com.au/2013/05/01/why-well-happily-pay-the-medicare-levy-just-dont-call-it-a-
tax/?wpmp_switcher=mobile 
 
11
 Citizens' Dialogue on the Future of Health Care in Canada. Website  http://participedia.net/en/cases/citizens-
dialogue-future-health-care-canada 
 
7 
 
 Are the difficulties in meeting health care costs genuine affordability issues or ‘cash flow’ 
problems? 
 Which consumers are meeting the existing MBS/PBS safety-nets? 
 What is the impact of financial imposts on these people’s timely access to services, ability to 
receive needed treatment, compliance with recommended treatment and medication regimes? 
 Do financial barriers to accessing care result in potentially preventable hospitalisations?  
 
The business case for doctors 
We need to understand more about what is important to GPs and specialists in the business sense. Too 
often policy changes in this area are driven by political or budgetary exigencies and ignore the day-to-
day realities of general practice. It is no surprise then when these policy changes fail to deliver on the 
expected outcomes and/or have unintended negative consequences.  
Working with the profession to manage resource allocation is critical to successful outcomes in this, as 
in other areas of general practice. Given the diversity of medical practices it is likely that there will not 
be one single solution to improving the way in which we deal with OOP costs for Medicare-funded 
services.  
Most information on doctors’ views and preferences comes from the professional colleges and guilds 
but their position on specific issues is not necessarily representative of that of doctors at the coal face. 
Broader consultation with the medical profession and with others working in general practice, including 
practice nurses, nurse practitioners, practice managers and Aboriginal Health Workers, would assist in 
obtaining their views on how best to manage OOP costs.   
This consultation process should focus on the following questions: 
 
 What do GPs and specialists like and dislike about co-payments?   
 What do they see as the (realistic) alternative?  
 What drives doctors to spend more / less time with a patient?   
 What patients / issues do they see as time-wasting? 
 What role do practice nurses, Aboriginal Health Workers and other practice staff in minimising 
out-of-pocket costs for primary health care?  
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Areas for consideration for policy development 
 
Registration with general practice  
Patient enrolment formalises a relationship between a health care professional / health care practice 
and the patient. The formal patient links with an identifiable source of care are variously known as 
registration, enrolment, rostering or personal lists. 
 
This formalisation of a commitment by both patient and service provider about the provision of primary 
care services is potentially beneficial for both.12 For the patient, it can provide a clearer or firmer 
guarantee of continued care from a single, known source and help with referrals to other health services 
as required. This in turn is likely to lead to better health outcomes, all other things being equal, due to 
improved continuity of care. For the service provider, enrolment can give greater certainty in some 
aspects of clinical practice, given the provider’s relationship with and knowledge of the patient’s history 
and current health issues.13 While patient enrolment is not sufficient to ensure coordination and 
continuity of care, it is seen in many quarters as a critical foundation for good primary care.   
 
We recommend exploring the value of having people most at risk of high OOP costs register with a GP / 
general practice of their choice to help with coordinated care and follow-up.  Registration could be 
extended to pharmacists / pharmacies to ensure appropriate use of medicines.   
 
This approach could help reduce OOP costs in the following ways: 
 
 Patient incentives to register could include the removal of co-payments and / or subsidies for 
OOP costs.  
  There will potentially be a decrease in duplicate tests and better continuity and coordination of 
care.  
 GPs will know the disease burden of their patients and this provides the opportunity to 
restructure Medicare payments to take account of this, for example, by providing for longer 
consultations.  
If patient enrolment resulted in savings through, for example, reduced testing and hospitalisation, these 
would off-set the costs of subsidising OOP costs for this group of patients.   
 
Better utilisation of the health workforce 
There is growing recognition of the need to reorient the primary care system towards multidisciplinary 
care teams and not rely solely on GPs as the providers of care. To date the rhetoric has not been 
matched by the practice.  
                                                          
12
 Kalucy L, Katterl R, Jackson-Bowers E & Hordacre A-L.  Models of Patient Enrolment.  PHCRIS 2009.  
http://www.phcris.org.au/phplib/filedownload.php?file=/elib/lib/downloaded_files/publications/pdfs/news_8363.
pdf 
 
13
 Manious AG, Baker R, Love M et al.  Continuity of care and trust in one’s physician: evidence from primary care 
in the US and UK. Family Medicine 2001; 333: 22-27.  http://www.stfm.org/Fullpdf/Jan01/special.pdf 
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There are currently 11,000 nurses in general practices in Australia but they are very under-utilised. 
There are many areas where nurses can provide needed care cost-effectively and in ways that can free 
busy doctors for those patients who need their specific skills.14 Similar arguments can be made for allied 
health professionals, community and Aboriginal health workers, midwives and nurse practitioners.  
There’s also a case for including pharmacists and dental professionals on this list. 
Too often in Australia suggestions about expanding scopes of practice degenerate into arguments about 
professional turf which ignore training, skills and best use of resources. We acknowledge that issues 
around scope of practice are inextricably linked to patient safety and note that they are necessary in the 
pursuance of good clinical governance. On the other hand, making optimal use of the full primary care 
workforce can ensure timely access to high quality and culturally sensitive care. The real challenge is to 
structure the reimbursement mechanisms to reward skills and training, ensure the appropriate degree 
of professional independence, encourage teamwork and limit costs to individuals. To date there has 
been no real willingness to tackle these issues which offer some real potential to reduce OOP costs and 
health inequalities. 
There is also a need to look at the relationship between workforce density and OOP costs. There are 
some clear patterns of high levels of bulk billing corresponding to areas of high doctor density. This 
brings up the question of whether a more equitable workforce distribution might help ensure a 
more equitable distribution of OOP costs across the population.   
 
Reconsidering the GP gatekeeper role 
The role of the GP as gatekeeper / coordinator of services is one of the keys of success of the Australian 
health care system.  We do not advocate changing this in any substantial way; what we do advocate is a 
fresh look at this role to see where it is necessary and where it is anachronistic. Money is not necessarily 
wasted when a patient sees a GP for the renewal of a long-standing prescription or for a referral to a 
specialist for diagnostic imaging. But does this need to happen all the time for every patient?  Is there 
scope in some areas and for some patients for other health professionals, such as practice nurses or 
pharmacists, to provide some gatekeeper/coordination services (see the section above)? 
We believe that the GP gatekeeper role should be scrutinised to determine if there are some areas 
where it is unnecessary and increases costs for both patients and Medicare. Current concerns about co-
payments have focused on reducing patient- driven GP visits, but the need for repeat or other 
prescriptions and renewal of specialist referrals creates opportunistic GP contact. Reducing this 
‘enforced’ contact carries a risk and managing this risk requires assessment of the need to alter scopes 
of practice and improve coordination of care.15 
 
                                                          
14 See for example Harris M & Lloyd J.  The role of Australian primary health care in the prevention of chronic 
disease. Review commissioned by the Australian National Preventive Health Agency. September 2012. 
http://www.anpha.gov.au/internet/anpha/publishing.nsf/Content/28433043152D3FD5CA257B7E00270FED/$File/
M%20Harris%20paper%202012%20-%20final.pdf  
 
15
 Nydam K. Gatekeeper, shopkeeper, scientist, coach? Australian Family Physician 2012 41(7): 457. 
http://www.racgp.org.au/afp/2012/july/gatekeeper,-shopkeeper,-scientist,-coach/ 
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Tackling over-testing and over-prescribing 
Almost every doctor visit generates additional costs from prescriptions, diagnostic tests and 
investigations. Over the past decade there has been a significant increase in the proportion of problems 
for which pathology and / or imaging was ordered.16 Some of this is a consequence of new technologies, 
and some is due to better management of chronic conditions. But some is over-utilisation.  For example 
a 2007 study by the Commonwealth Find found that 15% of Australians reported undergoing repeat 
imaging.17 The escalated use of diagnostic imaging has also been associated with the potential for 
‘treatment cascades’ that subsequently lead to procedures that may be of low value to patients or even 
unnecessary.18 
Australia has done little in terms of quality and quantity control of tests ordered and understanding 
prescribing patterns by GPs and specialists. There is much more that can and should be done in terms of 
external quality reviews and peer reviews to identify where doctors are ordering tests and prescribing 
inappropriately or unnecessarily. A more contentious possibility is that Medicare develops set packages 
of tests, with some flexibility for implementation, for certain common conditions (eg back pain, chest 
pain) and reimburses only for this package. This approach could certainly constrain Medicare costs; it 
would need patient education to ensure OOP costs did not grow as a consequence. 
An initial step would be to work with the medical profession and consumers to identify areas in which 
over-testing and / or prescribing is common and to develop standardised packages of tests and 
medication regimes which support quality clinical practices in these areas.  
 
Establishment of community health centres with salaried staff 
In the interests of pragmatism we are not proposing the abolishment of fee-for-service (FFS) which is 
the basis of the majority of Medicare payments to doctors, and coincidentally, the reason for increasing 
OOP costs. However we do conclude that there is strong support among most stakeholders (if not 
organised medicine) for the establishment of community health centres with salaried staff in medically 
under-served and lower socio-economic status areas. These would be similar to the current Aboriginal 
Community Controlled Health Organisations or the US model of community health centres.19 Such 
centres are extremely effective at meeting local needs and addressing health inequalities. 
A decreasing number of such centres, funded by the states, exist. However in this case the proposal is 
for Commonwealth funding on the basis of local needs and disease burden, with a bundling of MBS and 
                                                          
16 Britt H, Miller GC, Henderson J, et al. A decade of Australian general practice activity 2004–05 to 2013–14. 
General practice series no. 37. Sydney: Sydney University Press, 2014 
http://ses.library.usyd.edu.au/bitstream/2123/11883/4/9781743324240_ONLINE.pdf 
 
17 Commonwealth Fund International Health Policy Survey of Sicker Adults. 2008. 
http://www.commonwealthfund.org/Content/Surveys/2008/2008-Commonwealth- 
Fund-International-Health-Policy-Survey-of-Sicker-Adults.aspx 
 
18
 Canadian Agency for Drugs and Technology in Health. Appropriate utilization of advanced diagnostic imaging 
procedures: CT, MRI, and PET/CT. Environmental scan. February 2013. 
http://www.cadth.ca/media/pdf/PFDIESLiteratureScan_e_es.pdf 
 
19
 Hing E and Hooker RS. Community Health Centers: Providers, Patients and Content of Care. NCHS Data Brief No 
65, July 2011.  http://www.cdc.gov/nchs/data/databriefs/db65.htm 
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PBS funds. There could be a requirement for contributions from States and Territories as they would 
arguably benefit from reduced Emergency Department attendances and hospitalisations.  A key 
requirement would be that there are no copayments or deductibles for patients. 
It is anticipated that there are doctors who would welcome the opportunity to work in such centres, 
which have the potential to offer all that is needed for primary health care, with the integration of 
health and social services. Employment could be made more attractive by offering recent health care 
graduates the possibility of reducing their education debts. It is critical that the establishment of these 
centres is managed in conjunction with GPs and other health care providers in the local area to ensure 
that they address an unmet need for care rather than duplicate existing services.   These centres would 
not address the problems with OOP costs for all consumers but could provide a partial solution in areas 
in which high OOP costs are driven by workforce shortages.   
 
Increasing the value of existing health expenditure 
As there are always limits on our health budget, it is essential that we ensure that all health funding is 
allocated to achieve maximum benefit.  Improving the value we obtain from our existing expenditure on 
health care will help take pressure off our health budgets and reduce the need to increase consumer co-
payments.  Before consumers are asked to increased their direct contribution to health care, all 
reasonable measures should be implemented to increase the benefits obtained from existing health 
funding sources.  The following examples provide practical suggestions for achieving this aim.  
Identification of low-value health care procedures 
While some work has commenced on reviewing MBS items 20and identifying low-value health care 
practices21, a concerted effort is required in this space, together with education and incentives to 
encourage disinvestment in these. This will not necessarily address OOP costs but will ensure better 
value for spend. 
 
By taking an approach like the Choosing Wisely program22 this work can be undertaken by the medical 
professions at the coal face, rather than bureaucrats in Canberra. The involvement of consumers and 
patients during the decision- making process and in individual discussion with their clinicians also 
provides an opportunity for them to understand the value and the cost of their treatment. 
 
Increased professional development activities focused on identifying and reducing low- value 
procedures and peer review processes which support doctors to make better treatment 
recommendations would assist in reducing the numbers of low- value practices funded by Medicare. 
                                                          
20
 Department of Health. MBS reviews.  
http://www.msac.gov.au/internet/msac/publishing.nsf/Content/reviews-lp 
 
21
 Elshaug AG, Watt AM, Mundy L, Willis CD. Over 150 potentially low-value health care practices: an Australian 
study. Med J Aust 2012; 197(10):556-560. https://www.mja.com.au/journal/2012/197/10/over-150-potentially-
low-value-health-care-practices-australian-study 
 
22
 ABIM Foundation. Choosing Wisely. http://www.choosingwisely.org/ 
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The main outcome of this approach is around quality care and sustainable costs, but there will also be 
financial benefits that accrue to patients. 
 
Improving Clinical practices 
Low value services are linked to over-testing and over-prescribing (see above) and also to unwarranted 
variation in health care services. While some work has begun around exploring and understanding 
health care service variation,23 Australia has been slow to address this important area.   
 
There is evidence of significant medical practice variation in Australia, indicating that current practices 
do not represent the best value for our health dollars. For example, the Australian Council on Safety and 
Quality in Health Care has found a sevenfold variation in cardiac catheterization between the highest 
and lowest intervention Medicare Local area.24  There is also some evidence indicating that over-
servicing and over-testing occurs in some areas of our health system, for example, testing for Vitamin D 
levels25.  Strategies to reduce these practices should be developed and implemented, in conjunction 
with the medical profession and consumers, in order to ensure the best value is obtained for the health 
care dollars spent by both patients and governments. 
 
Increased generic substitution  
A 2013 paper from the Grattan Institute highlights that the Australian Government could save at least 
$550 million every year by encouraging doctors, pharmacists and patients to increase the uptake of 
generic drugs and bargaining harder on the price paid for generics.26 
The average annual increase in OOP costs for prescription pharmaceuticals over the last 14 years has 
been 2.1%, compared with 2.8% for the entire CPI. 27
   
However for many people with multiple 
prescriptions the costs of their medicines are prohibitive, leading to scripts not filled and doses skipped.  
 
                                                          
23
 Australian Commission on Safety and Quality in Health Care and Australian Institute of Health and Welfare. 
Exploring Healthcare Variation in Australia: Analyses Resulting from an OECD Study. Sydney: ACSQHC, 2014.  
http://www.safetyandquality.gov.au/wp-content/uploads/2014/05/Exploring-Healthcare-Variation-in-Australia-
Analyses-Resulting-from-an-OECD-Study.pdf 
 
24
 Australian Council on Safety and Quality in Health Care (ACSQHC) Medical Practice Variation: Background Paper 
Sydney: ACSQHC, 2013.  http://www.safetyandquality.gov.au/wp-
content/uploads/2013/10/SAQ110_Medical_Practice_variation_V10_WEB.pdf  
 
25
 Morgan s and Coleman J We live in testing times: Teaching rational test ordering in general practice. Aust Fam 
Physician 2014; 43 (5): 273-276. http://www.ncbi.nlm.nih.gov/pubmed/24791766  
 
26
 Duckett S. Australia’s bad drug deal. High pharmaceutical prices. Grattan Institute. March 2013. 
http://grattan.edu.au/wp-content/uploads/2014/04/Australias_Bad_Drug_Deal_FINAL.pdf 
 
27
 Pharmacy Guild of Australia. Submission to  Senate Standing Committees on Community Affairs Inquiry:  
Out-of-pocket costs in Australian healthcare. May 2014. 
http://www.aph.gov.au/parliamentary_business/committees/senate/community_affairs/australian_healthcare/~/
media/committees/clac_ctte/australian_healthcare/report.pdf 
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The case can be made that for certain people who need a substantial number of regular medications, 
PBS co-payments should be reduced further to ensure affordable access and compliance with 
medication regimes. In such cases simply providing a safety net does not assist people who are high 
users of medicines and on a low income as they are unable to meet the costs necessary to  reach the 
safety net threshold.  
 
 
Transparency around specialist fees 
In recent years Government action has been taken to address blow-outs in the costs of the Extended 
Medicare Safety Net attributed to exorbitantly high fees being charged by some specialists.28  
Some evidence can be gleaned from Medicare data that there has been a substantial increase in 
Medicare reimbursements for specialists in recent years, particularly to cardiologists, ophthalmologists, 
gastroenterologists and anaesthetists.  Anecdotal evidence indicates that there is a wide range of fees 
charged, with some specialists charging dramatically more than the AMA recommended fee (which is 
itself higher than the MBS reimbursement).  However there is no evidence that specialists charging the 
highest fees deliver the best outcomes. 
We therefore would like to see greater transparency around specialists’ outpatient fees and the OOP 
costs to the patient. Patients and referring GPs might make different choices about specialist care if they 
knew the costs involved. At the very least the major outliers should be named and shamed. It is also 
important that consumers are provided with comprehensive information about their health care choices 
and are made aware of options, such as public outpatient clinics, where they can receive specialist 
services at no (or lower) cost.   
 
Consumer payment strategies 
Problems associated with OOP costs for Medicare-funded services for consumers are a function of a 
range of different factors, including the following: 
 Their disposable income;  
 Their total health care costs; 
 The duration of their illness/disability; 
 The predictability of their illness/disability; 
 The impact of their illness/disability on their employment; 
 The non-health care costs associated with their illness/disability; and  
 Their level of savings/emergency funds. 
Where OOP costs are considered reasonable, there may be a role for supporting consumers to afford 
their medical expenses through strategies which target the timing of payments. For example, 
unexpected health care expenses can create a barrier to accessing care for people who may not have a 
                                                          
28
 CHERE. Extended Medicare Safety Net. Review of capping arrangements. Report 2011. 
http://www.health.gov.au/internet/main/publishing.nsf/Content/2011_Review_Extended_Medicare_Safety_Net/
$File/Final%20Report%20-%20Review%20of%20EMSN%20benefit%20capping%20June%202011.pdf 
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problem meeting these costs over the longer term. There may be a role for the Government to provide  
low or no interest loans to people to assist them in meeting high, short-term health care costs.    
15 
 
Conclusion 
 
Many of the issues we have laid out for consideration highlight the growing need to focus on delivering 
value and quality in health care.  The US health care system demonstrates in many ways that the most 
expensive care is not necessarily the best care, so it is in the best interests of all the funders of health 
care  – governments, private health insurers and especially patients – to determine that their money is 
spent as wisely and as well as possible.   
At the same time it is necessary to ensure that those with the greatest health care needs are protected 
from the cost barriers that limit their access to needed services. Failure to do this has consequences well 
beyond the individual, with increased acute care and disability costs and reduced productivity. 
In part because overall Australian health outcomes - as indicated by broad measures like life expectancy 
and infant mortality - are so good we have allowed ourselves to be blinded to the increasing erosion of 
the universality of Medicare and the subsequent widening in health disparities. Under a truly universal 
health care system we all pay in according to our means and take out according to our needs. We never 
know when or if the time will come for even the wealthiest of us to receive health care costing well 
beyond any expectations. 
We are well aware that these proposals for addressing OOP costs will be seen as controversial, even 
outrageous, by some. Our purpose is to galvanise thought, evidence and action to address this key issue 
of fairness and equity. 
We look forward to your comments and your own proposals. 
 
 
